About Genvax Technologies
Genvax Technologies is a Healthcare company based in Ames (United States) founded in 2021 by Hank Harris. Vaccines for animal diseases are developed using mRNA nanoparticles. Genvax Technologies has raised $9.9 million across 5 funding rounds from investors including Summit Agricultural Group, United States Department of Agriculture and United Animal Health. Genvax Technologies offers products and services including mRNA Nanoparticle Vaccines. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Companion Animals. Its legal entity is Genvax Technologies, Inc. Its competitors include Man’s Best Friends Therapeutics and WPM; 2 of its 2 listed competitors have raised funding.
Company details
Genvax Technologies was established in 2021 in Ames, United States, within the biotechnology sector. Operations center on the creation of vaccines targeting animal diseases. Emphasis is given to next-generation mRNA-based nanoparticle formulations, which are engineered to activate immune responses in animals. Development activities are conducted to address veterinary health needs through innovative immunization approaches.
- Headquarters Ames, United States
- Founders Hank Harris
- SectorsHealthcare
- Email••••••••
- Website genvax.com
- Social LinkedIn X
- Legal Name Genvax Technologies, Inc
- Total Equity Funding$9.9M (USD)
in 5 rounds
- InvestorsSummit Agricultural Group
& 6 more
Products & Services of Genvax Technologies
Genvax Technologies offers a comprehensive portfolio of products and services, including mRNA Nanoparticle Vaccines.
Develops vaccines to prevent and treat animal diseases using mRNA technology
Funding Insights of Genvax Technologies
Genvax Technologies has successfully raised a total of $9.9M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.9M
- Total Rounds 5
- First Round $145,000
(Apr 2022)
- Investors Count 7
All 5 funding rounds of Genvax Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2025 | Seed | – | United Animal Health | – | |
| Jun 2024 | $3.4M | Seed | – | – | – |
| Jul 2023 | $175,000 | Grant | – | – | |
| Jun 2022 | $6.5M | Seed | – | United Animal Health | |
| Apr 2022 | $145,000 | Grant | – | – |
7 investors in total: 7 institutional.
Investors in Genvax Technologies
Genvax Technologies has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Summit Agricultural Group, United States Department of Agriculture and United Animal Health.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed-stage investments and mentorship are provided to agricultural startups. | agstartupengine.com | Ames, United States | ||
| johnsonvilleventures.tcc.mode | ||||
Research-based nutrition products are provided for livestock farmers. | 1956 | unitedanh.com | Sheridan, United States | |
Leadership is provided on agriculture, food, and rural development matters. | 1862 | usda.gov | ||
Iowa Corn is focused on supporting corn growers and promoting corn usage. | iowacorn.org | Johnston, United States | ||
Agricultural products including crops and livestock are produced and supplied. | 1990 | summitag.com | Webster City, United States | |
Funds research in agroecosystems, food systems, and agricultural innovation. | 2014 | foundationfar.org |
Investor details for Genvax Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Genvax Technologies
2 people are tracked at Genvax Technologies (2 in leadership).
| Name | Role | Group |
|---|---|---|
Hank Harris | Co-Founder | Leadership |
Joel Harris | Chief Executive Officer | Leadership |
Complete people profiles for Genvax Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Genvax Technologies
3 dated milestones of Genvax Technologies across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Genvax Technologies is founded.
- Funding First funding round of $145K.
- Funding Latest funding round, Seed,.
Competitors of Genvax Technologies
Genvax Technologies has 2 listed competitors in our database, 2 of them funded. They include Man’s Best Friends Therapeutics and WPM.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| mbftherapeutics.com | 2008 | Ambler, United States | $2.7M | Gene-based vaccines for companion animal diseases are developed. | ||
| wildlifepm.com | 2019 | Albuquerque, United States | $104,981 | Vaccine delivery systems for wild and feral animals are developed. |
Detailed competitors of Genvax Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Veterinary Digital Health
3 companies that operate in the same segment as Genvax Technologies (Veterinary Digital Health) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | |||
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | |||
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Genvax Technologies
Complete news archive for Genvax Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genvax Technologies
Genvax Technologies was founded in 2021 and raised its 1st funding round 1 year after it was founded.
Genvax Technologies is headquartered in Ames, United States. It is registered at Ames, Iowa, United States.
Genvax Technologies is a funded company, having raised a total of $9.9M across 5 funding rounds to date. The company's 1st funding round was a Grant of $145K, raised on Apr 2022.
Genvax Technologies was established in 2021 in Ames, United States, within the biotechnology sector. Operations center on the creation of vaccines targeting animal diseases. Emphasis is given to next-generation mRNA-based nanoparticle formulations, which are engineered to activate immune responses in animals. Development activities are conducted to address veterinary health needs through innovative immunization approaches.
Genvax Technologies's top competitors include Man’s Best Friends Therapeutics and WPM.
Genvax Technologies offers mRNA Nanoparticle Vaccines.
Genvax Technologies has 7 investors. Key investors include Summit Agricultural Group, United States Department of Agriculture, United Animal Health, Iowa Corn, and Ag Startup Engine.
Genvax Technologies operates through Genvax Technologies, Inc.